CareDx director Riggsbee’s trust plans $823K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CareDx, Inc. (CDNA) director Richard Bryan Riggsbee’s Revocable Trust, with Riggsbee as trustee, reports a planned sale of 10,570 common shares with an aggregate market value of $823,192. The shares were acquired from the issuer through RSU vesting on June 14, 2025. The notice lists November 16, 2026 as the approximate sale date and says the shares will be sold that day or within three months of the notice. It lists August 4, 2026 in the field for a Rule 10b5-1 plan adoption or instruction date.
Key Figures
Key Terms
Rule 10b5-1 regulatory
RSU Vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.